Evidence map›Paper›PMID 25684977›Full record

ArticleMolecular vision2015

Ophthalmological phenotype associated with homozygous null mutation in the NEUROD1 gene.

Orsolya Orosz, Miklós Czeglédi, Irén Kántor, István Balogh, Attila Vajas, Lili Takács, András Berta, Gergely Losonczy

Open access · greenAbstract readCase Reports
In one paragraph

Article in Molecular vision, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Orsolya OroszDepartment of Ophthalmology, University of Debrecen, Clinical Center, Debrecen, Hungary.
Miklós CzeglédiDepartment of Ophthalmology, Jósa András Hospital, Nyíregyháza, Hungary.
Irén KántorDepartment of Pediatrics, Jósa András Hospital, Nyíregyháza, Hungary.
István BaloghDivision of Clinical Genetics, Department of Laboratory Medicine, University of Debrecen, Clinical Center, Debrecen, Hungary.
Attila VajasDepartment of Ophthalmology, University of Debrecen, Clinical Center, Debrecen, Hungary.
Lili TakácsDepartment of Ophthalmology, University of Debrecen, Clinical Center, Debrecen, Hungary.
András BertaDepartment of Ophthalmology, University of Debrecen, Clinical Center, Debrecen, Hungary.
Gergely LosonczyDepartment of Ophthalmology, University of Debrecen, Clinical Center, Debrecen, Hungary.
University of Debrecen · HUJósa András Múzeum · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeNEUROD1 is a tissue-specific basic helix loop helix (bHLH) protein involved in the development and maintenance of the endocrine pancreas and neuronal elements. Loss of NEUROD1 causes ataxia, cerebellar hypoplasia, sensorineural deafness, and severe retinal dystrophy in mice. Heterozygous loss-of-function mutations in NEUROD1 have previously been described as a cause of maturity-onset diabetes of the young (MODY) and late-onset diabetes. To date, homozygous loss-of-function NEUROD1 mutations have only been detected in two patients. Both mutations caused permanent neonatal diabetes and severe neurologic defects, including visual impairment. However, a detailed ophthalmological phenotype of this novel syndrome has not yet been reported. Our aim was to characterize the ophthalmological phenotype associated with the previously reported homozygous c.427_428CT mutation in the NEUROD1 gene.

methodsThe female patient was investigated on multiple occasions between 2009 (age 14) and 2014 (age 19), including visual acuity testing, automated perimetry, funduscopy, anterior-segment imaging, optical coherence tomography of the posterior pole, standard full-field electroretinography, and fundus-autofluorescence imaging.

resultsThe patient had nyctalopia, blurry vision, and visual field constriction from early childhood. Her best corrected visual acuity ranged between 20/25 and 15/25 during the investigation period. Perimetry showed concentric constriction of the visual field, sparing only the central 30 degrees in both eyes. The anterior segment did not show any morphological changes. Optical coherence tomography revealed total absence of the photoreceptor layer of the retina outside the fovea, where a discoid remnant of cone photoreceptors could be detected. Neither setting of the standard full-field electroretinography could detect any electrical response from the retina. Color fundus photos presented peripheral chorioretinal atrophy and central RPE mottling. A hyperreflective parafoveal ring was detected on fundus autofluorescent photos, a characteristic sign of hereditary retinal dystrophies.

conclusionsTo the best of our knowledge, this is the first report on the ophthalmological phenotype associating with a homozygous NEUROD1 null mutation in humans. Our results indicate that the loss of NEUROD1 has similar functional and anatomic consequences in the human retina as those described in mice. The present description can help the diagnosis of future cases and provide clues on the rate of disease progression.

Indexed as

MutationBasic Helix-Loop-Helix ProteinsElectroretinographyFemaleFovea CentralisFundus OculiHomozygoteHumansNight BlindnessOphthalmoscopyPhenotypeRetinal Cone Photoreceptor CellsRetinal DegenerationRetinal Rod Photoreceptor CellsVisual FieldsYoung AdultBasic Helix-Loop-Helix ProteinsNEUROD1 protein, human

Identifiers

PMID25684977
PMCPMC4323689
OpenAlexW98721963

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.